|Articles|August 9, 2019
Requirements for Fully Integrated Service Offerings in a HPAPI and Cytotoxic Environment
Author(s)Lonza
• Advantages of using an integrated-service provider • Case study: HPAPI monoplant
Related Content
- Analytics
- Data and Artificial Intelligence
- Dosage Forms
- Drug Development
- Manufacturing
- Aseptic/Sterile Processing
- Equipment
- Process and Automation
- Manufacturing, Parenterals and Injectables
- Manufacturing, Biosimilars and Biobetters
- Manufacturing, Inhalation Drugs
- Manufacturing, Solid and Semi-Solid Dosage Drugs
- Manufacturing, Cell Therapies
- Manufacturing, Biologic Drugs
- Supply Chain
- Manufacturing, Gene Therapies
- Packaging and Distribution
- Outsourcing
- Quality Systems